Search results
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
Simply Wall St. via Yahoo Finance· 16 hours agoMultiple insiders secured a larger position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares over...
This Is What Whales Are Betting On Sarepta Therapeutics - Sarepta Therapeutics (NASDAQ:SRPT)
Benzinga· 1 day agoLoading... Loading... High-rolling investors have positioned themselves bullish on Sarepta Therapeutics SRPT , and it's important for retail traders to take note. \This activity ...
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
Zacks· 1 day agoRevenues in the last quarter were impacted by a $10.3 million recognition adjustment owing to Regeneron Pharmaceuticals (REGN Quick QuoteREGN - Free Report) extending the technology collaboration ...
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 16 hours agoAmgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings...
Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note
Zacks via Yahoo Finance· 4 days agoTransMedics has an expected earnings growth rate of 81.8% for 2024. TMDX surpassed earnings in each...
Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoStrong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to...
Edgewise gets EU orphan drug status for muscular dystrophy drug (NASDAQ:EWTX)
Seeking Alpha· 3 days agoEdgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.